- Clinical data demonstrates a positive benefit for patients in septic shock - Significant improvement in cardiovascular function was observed - Mortality benefit in the pre specified per protocol patient population with a MODS score greater than nine was 5% - Mortality benefit increased significantly as a function of the amount of endotoxin removed, reaching 18% - Company plans to meet with FDA to discuss regulatory pathway